State of Alaska Department of Revenue lessened its position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) by 24.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,451 shares of the medical instruments supplier’s stock after selling 4,390 shares during […]
Shares of Insulet Co. (NASDAQ:PODD – Get Rating) have received an average rating of “Buy” from the fifteen analysts that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and nine have issued a buy recommendation on the company. The average […]
Brokerages predict that Insulet Co. (NASDAQ:PODD – Get Rating) will announce $289.59 million in sales for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Insulet’s earnings, with the highest sales estimate coming in at $301.30 million and the lowest estimate coming in at $286.40 million. Insulet posted sales of $263.20 […]
Insulet Co. (NASDAQ:PODD – Get Rating) COO Charles Alpuche sold 6,000 shares of the company’s stock in a transaction that occurred on Monday, June 6th. The shares were sold at an average price of $215.32, for a total transaction of $1,291,920.00. Following the completion of the sale, the chief operating officer now directly owns 43,899 […]
Insulet (NASDAQ:PODD – Get Rating) had its price target cut by stock analysts at Morgan Stanley from $268.00 to $244.00 in a report released on Tuesday, Stock Target Advisor reports. The brokerage presently has an “equal weight” rating on the medical instruments supplier’s stock. Morgan Stanley’s target price would indicate a potential upside of 12.05% […]